Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite study sheds light on anthelmintic resistance
The barber pole worm is resistant to major anthelmintics
Barber pole worm study offers hope for new treatments

A new study of the barber pole worm has offered insights into how treatments work and why anthelmintic resistance may occur.

Barber pole worm, or Haemonchus contortus, is a parasitic worm that lives in the gut of sheep and other livestock worldwide, and is now resistant to all major anthelmintics.

To find out how and why resistance has occurred, the research team studied a strain of H contortus that is susceptible to all major treatments for parasitic worms.

Scientists identified five enzymes key to the survival of the barber pole worm, two of which are already being studied as potential drug targets – one against another type of worm, the other against Mycobacterium tuberculosis.

According to funding institute the Wellcome Trust, the barber pole worm is endemic on all UK farms and is a significant threat to global food security. It is estimated to cost the UK sheep industry more than £80 million each year.

"Getting to grips with genomes such as that of H contortus is our best option to tackle the issue of drug resistance and develop new drugs against parasitic worms," said Professor Neil Sargison, study author from the University of Edinburgh's Royal (Dick) School of Veterinary Studies.

The research team also identified a set of genes that were more active within the parasite's gut, and at certain stages of its life cycle. It is hoped this information will offer a source of potential drug and vaccine candidates.

Co-author Professor Jon Gilleard, of the University of Calgary, said: "Not only is this worm closely related to many other parasites of livestock it is also similar to some species of worms in humans.

"This makes it an extremely important model parasite species for experimental studies. Revealing new drug targets against H contortus could provide much-needed new treatment opportunities against parasitic worms in both animals and humans."

 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.